JP Stock MarketDetailed Quotes

4502 Takeda Pharmaceutical

Watchlist
  • 4069.0
  • +21.0+0.52%
20min DelayMarket Closed Aug 9 15:00 JST
6.47TMarket Cap44.64P/E (Static)

Takeda Pharmaceutical Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
84.31%170.3B
-26.69%716.34B
-5.14%278.59B
-61.28%146.45B
-9.99%198.91B
9.68%92.4B
-13.00%977.16B
-21.80%293.69B
8.84%378.23B
-5.22%220.99B
Net income from continuing operations
6.59%95.3B
-54.52%144.2B
-109.62%-2.99B
-11.24%105.76B
-177.71%-47.97B
-14.87%89.41B
37.74%317.04B
373.71%31.14B
106.07%119.15B
34.21%61.73B
Operating gains losses
-674.37%-3.43B
-550.25%-8.25B
-3,827.22%-7.07B
-63.84%413M
-419.36%-2.19B
224.46%597M
-77.63%1.83B
-104.77%-180M
-18.66%1.14B
-76.54%687M
Depreciation and amortization
12.08%192.22B
9.57%728B
15.70%186.74B
5.76%187.06B
8.86%182.7B
8.35%171.5B
13.93%664.4B
6.00%161.41B
20.10%176.88B
19.32%167.83B
Asset impairment expenditure
232.10%26B
132.97%150.02B
-29.83%15.74B
25.90%7.58B
447.50%118.87B
-45.01%7.83B
18.12%64.39B
-43.73%22.43B
-54.32%6.02B
1,411.98%21.71B
Unrealized gains and losses of investment securities
-127.27%-12M
420.10%20.76B
2,504.82%7.98B
233.32%12.92B
-162.58%-194M
-67.65%44M
135.65%3.99B
78.04%-332M
344.76%3.88B
104.33%310M
Remuneration paid in stock
-0.36%15.39B
16.81%70.87B
22.49%18.19B
13.45%18.71B
8.75%18.54B
25.63%15.44B
39.88%60.67B
31.21%14.85B
48.74%16.49B
37.17%17.04B
Deferred tax
-9.47%41.3B
-257.46%-91.41B
-365.38%-44.53B
-270.92%-44.5B
-1,804.26%-48.01B
-9.56%45.63B
-19.82%58.05B
139.32%16.78B
-183.46%-12B
-81.77%2.82B
Other non cashItems
-133.98%-80.77B
789.71%160.2B
208.01%80.88B
0.98%71.91B
-38.99%41.93B
26.62%-34.52B
-90.23%18.01B
-188.54%-74.89B
19.57%71.21B
36.91%68.72B
Change In working capital
46.87%-80.19B
-913.31%-256B
-58.59%59.38B
-423.60%-166.02B
105.05%1.59B
19.91%-150.95B
-125.62%-25.26B
-19.75%143.39B
-28.36%51.3B
-441.81%-31.49B
-Change in receivables
47.17%-47.74B
-79.90%15.1B
8.24%73.9B
11.88%14.29B
43.44%17.29B
-402.91%-90.37B
-40.98%75.13B
51.54%68.27B
-90.71%12.77B
190.27%12.06B
-Change in inventory
64.75%-10.08B
-46.22%-115.74B
128.38%12.75B
-173.82%-50.55B
-640.98%-49.35B
-213.54%-28.59B
-71.52%-79.16B
-552.83%-44.92B
-29.08%-18.46B
-68.35%-6.66B
-Change in payables and accrued expense
-8.08%-37.46B
88.33%-9.9B
-150.66%-30.48B
1,011.24%70.27B
62.57%-15.02B
64.32%-34.66B
-167.76%-84.8B
-52.61%60.17B
-206.42%-7.71B
-353.85%-40.14B
-Change in other current liabilities
-64.50%8.96B
-158.63%-18.57B
-121.61%-8.55B
-210.03%-44.19B
327.89%8.92B
157.20%25.25B
163.84%31.67B
2,453.23%39.58B
176.97%40.16B
-143.47%-3.92B
-Change in other working capital
127.10%6.12B
-497.82%-126.9B
-42.01%11.77B
-734.91%-155.83B
454.57%39.75B
-12.32%-22.58B
154.91%31.9B
69.00%20.29B
472.67%24.54B
320.35%7.17B
Tax refund paid
32.48%-35.5B
-8.64%-202.04B
-70.96%-35.73B
15.17%-47.38B
24.91%-66.35B
-152.12%-52.58B
-32.43%-185.97B
46.87%-20.9B
-105.22%-55.85B
-132.72%-88.36B
Cash from discontinued investing activities
Operating cash flow
84.31%170.3B
-26.69%716.34B
-5.14%278.59B
-61.28%146.45B
-9.99%198.91B
9.69%92.4B
-13.00%977.16B
-21.80%293.69B
8.84%378.23B
-5.22%220.99B
Investing cash flow
Cash flow from continuing investing activities
41.21%-156.69B
23.59%-463.86B
85.98%-61.49B
-61.20%-75.27B
-122.66%-60.58B
-181.41%-266.53B
-206.42%-607.1B
-1,610.32%-438.49B
32.47%-46.69B
17.31%-27.21B
Net PPE purchase and sale
-25.00%-57.43B
-19.41%-166.81B
-27.65%-44.53B
-39.82%-46.81B
-0.98%-29.52B
-9.16%-45.95B
-15.03%-139.7B
-2.08%-34.89B
-23.78%-33.48B
4.00%-29.24B
Net intangibles purchas and sale
64.01%-80.36B
38.08%-305.31B
95.15%-19.79B
-75.09%-30.04B
-184.64%-32.2B
-296.94%-223.28B
-685.27%-493.03B
-2,413.61%-408.31B
19.66%-17.16B
11.13%-11.31B
Net business purchase and sale
690.59%2.94B
150.80%19.96B
146.22%19.59B
--0
---7M
--372M
137.06%7.96B
-69.46%7.96B
--0
--0
Net investment purchase and sale
-20,018.32%-26.36B
-364.77%-32.05B
-844.17%-28.41B
-242.39%-2B
-114.36%-1.5B
-104.04%-131M
41.06%12.1B
-2,716.52%-3.01B
-29.20%1.41B
13.13%10.46B
Dividends received (cash flow from investment activities)
40.14%206M
270.33%13.19B
3,759.76%12.66B
-53.11%384M
--0
6.52%147M
4.73%3.56B
-59.15%328M
-66.65%819M
75,800.00%2.28B
Interest received (cash flow from investment activities)
86.52%4.33B
120.83%11.16B
28.91%2.92B
135.25%3.14B
181.95%2.78B
394.04%2.32B
73.14%5.05B
401.55%2.26B
290.64%1.34B
-44.51%986M
Net other investing changes
-92.86%-27M
-31.19%-4B
-38.37%-3.92B
-83.85%63M
65.36%-133M
93.78%-14M
58.35%-3.05B
-7.11%-2.83B
111.50%390M
48.80%-384M
Cash from discontinued investing activities
Investing cash flow
41.21%-156.69B
23.59%-463.86B
85.98%-61.48B
-61.21%-75.27B
-122.67%-60.58B
-181.41%-266.53B
-206.42%-607.1B
-1,610.32%-438.49B
32.47%-46.69B
17.32%-27.21B
Financing cash flow
Cash flow from continuing financing activities
647.58%316.38B
50.02%-354.42B
-782.03%-58.22B
77.52%-97.76B
-171.14%-140.65B
73.22%-57.78B
33.74%-709.15B
97.29%-6.6B
-158.81%-434.96B
79.03%-51.88B
Net issuance payments of debt
332.35%429.61B
100.53%1.51B
-149.19%-14.28B
127.61%73.49B
-1,358.81%-157.07B
367.62%99.37B
52.53%-285.07B
115.70%29.02B
-678.82%-266.2B
94.83%-10.77B
Net common stock issuance
19.09%-1.88B
91.36%-2.33B
--0
--0
--0
91.36%-2.33B
65.27%-26.93B
--0
--0
--0
Cash dividends paid
-5.63%-138.11B
-2.78%-287.19B
12.41%-9.13B
-7.18%-138.25B
18.58%-9.07B
-1.45%-130.75B
1.50%-279.42B
2.09%-10.42B
1.87%-128.99B
-16.70%-11.13B
Interest paid (cash flow from financing activities)
21.95%-15.47B
7.54%-100.38B
1.37%-21.69B
14.39%-28.97B
0.18%-29.9B
12.98%-19.82B
-0.32%-108.56B
5.57%-21.99B
-4.95%-33.84B
-1.69%-29.95B
Net other financing activities
1,091.92%42.23B
470.06%33.96B
-308.68%-13.13B
31.98%-4.03B
213,084.62%55.38B
-26,506.25%-4.26B
-2,283.64%-9.18B
-17,750.00%-3.21B
-1,572.88%-5.92B
---26M
Cash from discontinued financing activities
Financing cash flow
647.58%316.38B
50.02%-354.42B
-782.17%-58.22B
77.52%-97.76B
-171.14%-140.66B
73.22%-57.78B
33.74%-709.15B
97.29%-6.6B
-158.81%-434.96B
79.03%-51.88B
Net cash flow
Beginning cash position
-14.19%457.8B
-37.21%533.53B
-57.91%288.36B
-60.15%318.05B
-51.02%316.38B
-37.21%533.53B
-12.06%849.7B
-5.41%685.14B
31.30%798.14B
-1.36%645.99B
Current changes in cash
242.29%329.99B
69.94%-101.93B
204.94%158.88B
74.30%-26.58B
-101.64%-2.33B
-2.53%-231.91B
-133.40%-339.09B
-242.63%-151.4B
-193.75%-103.42B
401.19%141.91B
Effect of exchange rate changes
16.67%17.22B
14.28%26.2B
5,081.13%10.56B
67.48%-3.12B
-60.92%4B
-34.36%14.76B
-20.27%22.93B
-101.10%-212M
-255.83%-9.58B
13,021.79%10.24B
End cash Position
154.44%805.01B
-14.19%457.8B
-14.19%457.8B
-57.91%288.36B
-60.15%318.05B
-51.02%316.38B
-37.21%533.53B
-37.21%533.53B
-5.41%685.14B
31.30%798.14B
Free cash from
118.38%32.51B
-31.40%235.61B
242.47%214.26B
-78.84%69.33B
-28.56%128.86B
-1,151.06%-176.84B
-63.35%343.47B
-146.45%-150.39B
9.54%327.61B
-4.89%180.38B
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 84.31%170.3B-26.69%716.34B-5.14%278.59B-61.28%146.45B-9.99%198.91B9.68%92.4B-13.00%977.16B-21.80%293.69B8.84%378.23B-5.22%220.99B
Net income from continuing operations 6.59%95.3B-54.52%144.2B-109.62%-2.99B-11.24%105.76B-177.71%-47.97B-14.87%89.41B37.74%317.04B373.71%31.14B106.07%119.15B34.21%61.73B
Operating gains losses -674.37%-3.43B-550.25%-8.25B-3,827.22%-7.07B-63.84%413M-419.36%-2.19B224.46%597M-77.63%1.83B-104.77%-180M-18.66%1.14B-76.54%687M
Depreciation and amortization 12.08%192.22B9.57%728B15.70%186.74B5.76%187.06B8.86%182.7B8.35%171.5B13.93%664.4B6.00%161.41B20.10%176.88B19.32%167.83B
Asset impairment expenditure 232.10%26B132.97%150.02B-29.83%15.74B25.90%7.58B447.50%118.87B-45.01%7.83B18.12%64.39B-43.73%22.43B-54.32%6.02B1,411.98%21.71B
Unrealized gains and losses of investment securities -127.27%-12M420.10%20.76B2,504.82%7.98B233.32%12.92B-162.58%-194M-67.65%44M135.65%3.99B78.04%-332M344.76%3.88B104.33%310M
Remuneration paid in stock -0.36%15.39B16.81%70.87B22.49%18.19B13.45%18.71B8.75%18.54B25.63%15.44B39.88%60.67B31.21%14.85B48.74%16.49B37.17%17.04B
Deferred tax -9.47%41.3B-257.46%-91.41B-365.38%-44.53B-270.92%-44.5B-1,804.26%-48.01B-9.56%45.63B-19.82%58.05B139.32%16.78B-183.46%-12B-81.77%2.82B
Other non cashItems -133.98%-80.77B789.71%160.2B208.01%80.88B0.98%71.91B-38.99%41.93B26.62%-34.52B-90.23%18.01B-188.54%-74.89B19.57%71.21B36.91%68.72B
Change In working capital 46.87%-80.19B-913.31%-256B-58.59%59.38B-423.60%-166.02B105.05%1.59B19.91%-150.95B-125.62%-25.26B-19.75%143.39B-28.36%51.3B-441.81%-31.49B
-Change in receivables 47.17%-47.74B-79.90%15.1B8.24%73.9B11.88%14.29B43.44%17.29B-402.91%-90.37B-40.98%75.13B51.54%68.27B-90.71%12.77B190.27%12.06B
-Change in inventory 64.75%-10.08B-46.22%-115.74B128.38%12.75B-173.82%-50.55B-640.98%-49.35B-213.54%-28.59B-71.52%-79.16B-552.83%-44.92B-29.08%-18.46B-68.35%-6.66B
-Change in payables and accrued expense -8.08%-37.46B88.33%-9.9B-150.66%-30.48B1,011.24%70.27B62.57%-15.02B64.32%-34.66B-167.76%-84.8B-52.61%60.17B-206.42%-7.71B-353.85%-40.14B
-Change in other current liabilities -64.50%8.96B-158.63%-18.57B-121.61%-8.55B-210.03%-44.19B327.89%8.92B157.20%25.25B163.84%31.67B2,453.23%39.58B176.97%40.16B-143.47%-3.92B
-Change in other working capital 127.10%6.12B-497.82%-126.9B-42.01%11.77B-734.91%-155.83B454.57%39.75B-12.32%-22.58B154.91%31.9B69.00%20.29B472.67%24.54B320.35%7.17B
Tax refund paid 32.48%-35.5B-8.64%-202.04B-70.96%-35.73B15.17%-47.38B24.91%-66.35B-152.12%-52.58B-32.43%-185.97B46.87%-20.9B-105.22%-55.85B-132.72%-88.36B
Cash from discontinued investing activities
Operating cash flow 84.31%170.3B-26.69%716.34B-5.14%278.59B-61.28%146.45B-9.99%198.91B9.69%92.4B-13.00%977.16B-21.80%293.69B8.84%378.23B-5.22%220.99B
Investing cash flow
Cash flow from continuing investing activities 41.21%-156.69B23.59%-463.86B85.98%-61.49B-61.20%-75.27B-122.66%-60.58B-181.41%-266.53B-206.42%-607.1B-1,610.32%-438.49B32.47%-46.69B17.31%-27.21B
Net PPE purchase and sale -25.00%-57.43B-19.41%-166.81B-27.65%-44.53B-39.82%-46.81B-0.98%-29.52B-9.16%-45.95B-15.03%-139.7B-2.08%-34.89B-23.78%-33.48B4.00%-29.24B
Net intangibles purchas and sale 64.01%-80.36B38.08%-305.31B95.15%-19.79B-75.09%-30.04B-184.64%-32.2B-296.94%-223.28B-685.27%-493.03B-2,413.61%-408.31B19.66%-17.16B11.13%-11.31B
Net business purchase and sale 690.59%2.94B150.80%19.96B146.22%19.59B--0---7M--372M137.06%7.96B-69.46%7.96B--0--0
Net investment purchase and sale -20,018.32%-26.36B-364.77%-32.05B-844.17%-28.41B-242.39%-2B-114.36%-1.5B-104.04%-131M41.06%12.1B-2,716.52%-3.01B-29.20%1.41B13.13%10.46B
Dividends received (cash flow from investment activities) 40.14%206M270.33%13.19B3,759.76%12.66B-53.11%384M--06.52%147M4.73%3.56B-59.15%328M-66.65%819M75,800.00%2.28B
Interest received (cash flow from investment activities) 86.52%4.33B120.83%11.16B28.91%2.92B135.25%3.14B181.95%2.78B394.04%2.32B73.14%5.05B401.55%2.26B290.64%1.34B-44.51%986M
Net other investing changes -92.86%-27M-31.19%-4B-38.37%-3.92B-83.85%63M65.36%-133M93.78%-14M58.35%-3.05B-7.11%-2.83B111.50%390M48.80%-384M
Cash from discontinued investing activities
Investing cash flow 41.21%-156.69B23.59%-463.86B85.98%-61.48B-61.21%-75.27B-122.67%-60.58B-181.41%-266.53B-206.42%-607.1B-1,610.32%-438.49B32.47%-46.69B17.32%-27.21B
Financing cash flow
Cash flow from continuing financing activities 647.58%316.38B50.02%-354.42B-782.03%-58.22B77.52%-97.76B-171.14%-140.65B73.22%-57.78B33.74%-709.15B97.29%-6.6B-158.81%-434.96B79.03%-51.88B
Net issuance payments of debt 332.35%429.61B100.53%1.51B-149.19%-14.28B127.61%73.49B-1,358.81%-157.07B367.62%99.37B52.53%-285.07B115.70%29.02B-678.82%-266.2B94.83%-10.77B
Net common stock issuance 19.09%-1.88B91.36%-2.33B--0--0--091.36%-2.33B65.27%-26.93B--0--0--0
Cash dividends paid -5.63%-138.11B-2.78%-287.19B12.41%-9.13B-7.18%-138.25B18.58%-9.07B-1.45%-130.75B1.50%-279.42B2.09%-10.42B1.87%-128.99B-16.70%-11.13B
Interest paid (cash flow from financing activities) 21.95%-15.47B7.54%-100.38B1.37%-21.69B14.39%-28.97B0.18%-29.9B12.98%-19.82B-0.32%-108.56B5.57%-21.99B-4.95%-33.84B-1.69%-29.95B
Net other financing activities 1,091.92%42.23B470.06%33.96B-308.68%-13.13B31.98%-4.03B213,084.62%55.38B-26,506.25%-4.26B-2,283.64%-9.18B-17,750.00%-3.21B-1,572.88%-5.92B---26M
Cash from discontinued financing activities
Financing cash flow 647.58%316.38B50.02%-354.42B-782.17%-58.22B77.52%-97.76B-171.14%-140.66B73.22%-57.78B33.74%-709.15B97.29%-6.6B-158.81%-434.96B79.03%-51.88B
Net cash flow
Beginning cash position -14.19%457.8B-37.21%533.53B-57.91%288.36B-60.15%318.05B-51.02%316.38B-37.21%533.53B-12.06%849.7B-5.41%685.14B31.30%798.14B-1.36%645.99B
Current changes in cash 242.29%329.99B69.94%-101.93B204.94%158.88B74.30%-26.58B-101.64%-2.33B-2.53%-231.91B-133.40%-339.09B-242.63%-151.4B-193.75%-103.42B401.19%141.91B
Effect of exchange rate changes 16.67%17.22B14.28%26.2B5,081.13%10.56B67.48%-3.12B-60.92%4B-34.36%14.76B-20.27%22.93B-101.10%-212M-255.83%-9.58B13,021.79%10.24B
End cash Position 154.44%805.01B-14.19%457.8B-14.19%457.8B-57.91%288.36B-60.15%318.05B-51.02%316.38B-37.21%533.53B-37.21%533.53B-5.41%685.14B31.30%798.14B
Free cash from 118.38%32.51B-31.40%235.61B242.47%214.26B-78.84%69.33B-28.56%128.86B-1,151.06%-176.84B-63.35%343.47B-146.45%-150.39B9.54%327.61B-4.89%180.38B
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
JP
Overall
Symbol
Latest Price
% Chg